AzureCell Therapies, a Geneva, Switzerland-based biotech spin-off focused on regenerative cell therapy for Parkinson’s patients, raised €154,500 in a seed-related fundraising round led by Venture Kick with participation from MassChallenge Switzerland and FONGIT Innovation Fund.
More on tech.eu →


